Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
35.81
+0.15 (0.42%)
Jan 7, 2026, 11:29 AM EST - Market open
Moderna Market Cap
Moderna has a market cap or net worth of $13.99 billion as of January 7, 2026. Its market cap has decreased by -5.21% in one year.
Market Cap
13.99B
Enterprise Value
8.23B
1-Year Change
-5.21%
Ranking
Category
Stock Price
$35.81
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $13.99B, an increase of 128.69%. That is a compound annual growth rate of 12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 13.93B | 20.92% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 987.49B |
| Johnson & Johnson | 499.57B |
| AbbVie | 404.77B |
| UnitedHealth Group | 307.99B |
| AstraZeneca | 293.89B |
| Merck & Co. | 275.75B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |